Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by A4GALT catalyzes the transfer of galactose to lactosylceramide to form globotriaosylceramide, which has been identified as the P(k) antigen of the P blood group system. Additionally we are shipping A4GALT Proteins (6) and A4GALT Kits (1) and many more products for this protein.
Showing 10 out of 48 products:
Human Polyclonal A4GALT Primary Antibody for EIA, WB - ABIN951384
Zumbrun, Hanson, Sinclair, Freedy, Melton-Celsa, Rodriguez-Canales, Hanson, OBrien: Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. in Infection and immunity 2010
Show all 3 references for ABIN951384
Human Polyclonal A4GALT Primary Antibody for WB - ABIN2782908
Hellberg, Schmidt-Melbye, Reid, Olsson: Expression of a novel missense mutation found in the A4GALT gene of Amish individuals with the p phenotype. in Transfusion 2008
Human Polyclonal A4GALT Primary Antibody for WB - ABIN654075
Okuda, Nakayama: Identification and characterization of the human Gb3/CD77 synthase gene promoter. in Glycobiology 2008
Mutation in the A4GALT gene is associated with rare p phenotype in P1Pk blood group (show DARC Antibodies) system.
The results of this investigation demonstrate a consistent association of A4GALT SNPs rs2143918 and rs5751348 with the P1/P2 phenotypes and suggest that SNP rs5751348 may lead to allelic variations in A4GALT gene expression
these data elucidate a new explanation underlying the p phenotype, implicating the deleted regions of A4GALT as crucial for P1 and P(k) synthesis, possibly due to loss of binding sites for erythroid transcription factors.
P1-decorated PSGL-1 (show SELPLG Antibodies)/mIgG2b bound with high avidity to both Stx1 (show STX1A Antibodies) and Stx2 (show STX2 Antibodies), and as such constitutes a potential therapeutic inhibitor of these toxins.
Results suggest that the C631G mutation alters the acceptor specificity of Gb3/CD77 synthase, rendering it able to catalyze synthesis of the Gal (show GAL Antibodies)(alpha1-4)Gal (show GAL Antibodies) and Gal (show GAL Antibodies)(alpha1-4)GalNAc moieties.
Increased globotriaosylceramide levels are detected in a transgenic mouse expressing human alpha1,4-galactosyltransferase in a mouse model for treating Fabry disease.
Data showed that GRINA (show GRINA Antibodies)-C was associated with Gb3 synthase (show PK Antibodies), and may demonstrate a new type of posttranscriptional regulation of glycosyltransferases.
of A4GALT mRNA in cultured human bone marrow cells revealed novel transcripts containing only the noncoding exon 1 and a sequence (here termed exon 2a) from intron 1.
We established by quantitative real-time PCR that both fresh colonic epithelial sections and HCT-8 cells express Gb3 synthase (show PK Antibodies) mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
The P blood group (show DARC Antibodies) phenotype is due to several disctint nonfunctional alleles of A4GALT without any predominant allele.
The protein encoded by this gene catalyzes the transfer of galactose to lactosylceramide to form globotriaosylceramide, which has been identified as the P(k) antigen of the P blood group system. The encoded protein, which is a type II membrane protein found in the Golgi, is also required for the synthesis of the bacterial verotoxins receptor.
, GB3 synthase
, P blood group (P one antigen)
, P(k) antigen synthase
, P1/Pk synthase
, UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase
, globotriaosylceramide synthase
, lactosylceramide 4-alpha-galactosyltransferase
, Gb3 synthase
, Gb3/CD77 synthase
, alpha 1,4-galactosyltransferase (globotriaosylceramide synthase)